News
![GENERIUM has registered a biosimilar of ranibizumab, a medicine for treatment of age-related macular degeneration](/upload/iblock/041/qfwehqib6vq13jbl02vc5ax5s11d5vk1.png)
GENERIUM has registered a biosimilar of ranibizumab, a medicine for treatment of age-related macular degeneration
![The first biosimilar of romiplostim has been registered in Russia](/upload/iblock/abc/kp5n7krb2gfpflvis3bhdpgqjqcgsqjf.jpg)
The first biosimilar of romiplostim has been registered in Russia
![Launch of Generium’s Omalizumab Biosimilar for Atopic Bronchial Asthma Marks Selexis’ Ninth Commercial Product](/images/cap-press-center.jpg)
Launch of Generium’s Omalizumab Biosimilar for Atopic Bronchial Asthma Marks Selexis’ Ninth Commercial Product
![Expo 2020 in Dubai: Russian Pharma Industry Adapts to Pandemic, Open to Cooperation With Arab World](/upload/iblock/a8a/0lappnnu9b5u6yayfz60pp6wedtts2sz.jpg)
Expo 2020 in Dubai: Russian Pharma Industry Adapts to Pandemic, Open to Cooperation With Arab World
![Russia shows off new Covid-19 vaccine factory even as its people hesitate to get the shot](/upload/iblock/d70/f06ek7tz4mlsw2ubwv2zjw66dpxun34m.jpeg)
Russia shows off new Covid-19 vaccine factory even as its people hesitate to get the shot
![Talks on production of Russian vaccine in Serbia commence](/upload/iblock/5ef/jafd0hd3hp9u2z1zu20jqaanrus16eec.jpg)
Talks on production of Russian vaccine in Serbia commence
![GENERIUM launched the production of Sputnik V vaccine](/upload/iblock/87f/ovf2ln24lcz0xpeigu8fuml1h45sx8tb.jpg)
GENERIUM launched the production of Sputnik V vaccine
![First Russian omalizumab biosimilar registered for the treatment of severe bronchial asthma](/upload/iblock/e44/dzmauas2jy9s0wzde190b19trd5kzhkv.jpg)
First Russian omalizumab biosimilar registered for the treatment of severe bronchial asthma
![GENERIUM became the first company registered a unique combination of high-precision tests for the detection of antibodies of three classes to the SARS-CoV-2 coronavirus (COVID-19)](/upload/iblock/9f3/6w52jp9tyjexhe114d297n870ghy0hpl.jpg)
GENERIUM became the first company registered a unique combination of high-precision tests for the detection of antibodies of three classes to the SARS-CoV-2 coronavirus (COVID-19)